Correlation Between Pmv Pharmaceuticals and Enlivex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and Enlivex Therapeutics, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Enlivex Therapeutics.

Diversification Opportunities for Pmv Pharmaceuticals and Enlivex Therapeutics

-0.14

Correlation Coefficient

Pmv Pharmaceuticals  Enlivex Therapeutics

Good diversification

The 3 months correlation between Pmv and Enlivex is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Enlivex Therapeutics

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.54 times more return on investment than Enlivex Therapeutics. However, Pmv Pharmaceuticals is 1.84 times less risky than Enlivex Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  158.00  in Pmv Pharmaceuticals on October 10, 2024 and sell it today you would lose (4.00) from holding Pmv Pharmaceuticals or give up 2.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  Enlivex Therapeutics

Pmv Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Pmv Pharmaceuticals and Enlivex Therapeutics

The main advantage of trading using opposite Pmv Pharmaceuticals and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.

The idea behind Pmv Pharmaceuticals and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.